# Apremilast in the Treatment of Uveitis

> **NCT00889421** · PHASE1,PHASE2 · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 3 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT00889421
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Investigator discretion due to lack of efficacy in three subjects enrolled
- **Last updated:** 2014-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00889421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00889421, "Apremilast in the Treatment of Uveitis". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00889421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*